首页 | 本学科首页   官方微博 | 高级检索  
     

改进型颈动脉注射法递送新型基因运载体包裹绿色荧光示踪蛋白
引用本文:王 珏,王竞男,邓宇斌,杨立群. 改进型颈动脉注射法递送新型基因运载体包裹绿色荧光示踪蛋白[J]. 中国组织工程研究, 2014, 18(12): 1926-1931. DOI: 10.3969/j.issn.2095-4344.2014.12.020
作者姓名:王 珏  王竞男  邓宇斌  杨立群
作者单位:1中山大学附属第一医院转化医学中心,广东省广州市 5100802中山大学化学与化学工程学院高分子研究所,广东省广州市 510275
基金项目:广东省教育部产学研结合项目(2012B091100457)
摘    要:背景:超支化支链淀粉衍生物作为非病毒基因载体具有低毒性、转染率好的特点,但如何高效递送其进入机体内使有治疗作用基因成功表达的方式仍在探索中。目的:探讨包裹绿色荧光蛋白的新型基因运载载体经改进颈动脉注射法到达大鼠脑缺血损伤区的表达情况。方法:取雄性SD大鼠制作大脑中动脉梗死模型,24 h后随机分为2组,对照组以尾静脉注射包裹绿色荧光蛋白的超支化支链淀粉衍生物,实验组以改进型颈内动脉注射包裹绿色荧光蛋白的超支化支链淀粉衍生物。7 d后处死大鼠,取出脑组织,qPCR和Western blot检测大鼠脑组织中绿色荧光蛋白的基因和蛋白水平,免疫荧光法观察脑组织冰冻切片中血管内壁附近绿色荧光蛋白的表达。结果与结论:qPCR和Western blot检测结果均显示实验组大鼠脑组织中绿色荧光蛋白的表达量显著高于对照组(P < 0.05),免疫荧光观察结果显示绿色荧光蛋白在实验组血管内壁附近的表达高于对照组。在SD大鼠大脑中动脉梗死模型中,相比尾静脉注射法,改进型颈动脉注射法可显著促进脑缺血损伤区的超支化支链淀粉衍生物及绿色荧光蛋白在脑组织中表达的量。中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程全文链接:

关 键 词:生物材料  纳米材料  基因运载载体  支链淀粉衍生物  颈动脉注射  尾静脉注射  绿色荧光蛋白  基因转染  脑卒中  

Delivery of DMAPA-Amp wrapped green fluorescent protein by modified carotid injection
Wang Jue,Wang Jing-nan,Deng Yu-bin,Yang Li-qun. Delivery of DMAPA-Amp wrapped green fluorescent protein by modified carotid injection[J]. Chinese Journal of Tissue Engineering Research, 2014, 18(12): 1926-1931. DOI: 10.3969/j.issn.2095-4344.2014.12.020
Authors:Wang Jue  Wang Jing-nan  Deng Yu-bin  Yang Li-qun
Affiliation:1Research Center of Translational Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, Guangdong Province, China
2Institute of Polymer Science, School of Chemistry and Chemical Engineering, Sun Yat-sen University, Guangzhou 510275, Guangdong Province, China
Abstract:BACKGROUND:Hyperbranched cationic amylopectin is a kind of nonviral gene vectors with low toxicity and good transfection efficiency. However, searching for more efficient methods to delivery it into the body and making the genes expressed are being explored.OBJECTIVE:To study the expression of DMAPA-Amp wrapped green fluorescent protein (GFP) transferred by modified carotid injection into cerebral ischemic area.METHODS:Male Sprague-Dawley rats subjected to middle cerebral artery infarction were randomly divided into two groups after 24 hours: experimental group (injected with GFP entrapped DMAPA-Amp via the internal carotid artery) and control group (injected with GFP entrapped DMAPA-Amp via the tail vein). These rats were put to death and their brain tissue was removed after 7 days. The expression of GFP was detected by quantitative PCR and western blot assay, and immunofluorescence staining was performed to detect the expression of GFP located near cerebrovascular endothelial cells by frozen section. RESULTS AND CONCLUSION:Compared with the control group, the expression of GFP was much higher in the experimental group detected by quantitative PCR and western blot (P < 0.05). Additionally, the expression of GFP located near cerebrovascular endothelial cells by frozen section was also higher than that in the control group. Modified carotid injection could significantly promote the expression of hyperbranched cationic amylopectin derivates and GFP in the brain tissue of Sprague-Dawley rats undergoing middle cerebral artery infarction compared with tail vein injection, which indicates DMAPA-Amp and modified carotid injection may cast new lights on the therapy for angiogenesis of ischemic stroke.
Keywords:biocompatible materials   carotid arteries   injections   intra-arterial   green fluorescent proteins   transfection  
本文献已被 CNKI 等数据库收录!
点击此处可从《中国组织工程研究》浏览原始摘要信息
点击此处可从《中国组织工程研究》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号